The contractor shall propose novel, low-cost, real-time point-of-care (POC) assays for HIV viral load monitoring, HIV drug resistance monitoring, and pharmacological adherence monitoring.
Ended Definitive Contract Awarded Last action
- Contract number
- 75N93021C00030
- Awardee
-
Zymeron Corporation UEI GAMMMRQ6QMN1
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $299,988
Award facts
- Opportunity
-
- A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proprosals Pre-Solicitation · SBIRPHS20211 · Posted Jul 9, 2020
- Rapid Point of Care Test to Quantify HIV Drugs for Adherence Monitoring Award Notice · Posted Jul 1, 2021
- Contract value 100% obligated
- $299,988.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 6 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Durham, NC 27709, USA
- Research
- SBIR Program Phase I Action
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $299,988 |
About this award
This is a $299,988 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Zymeron Corporation, a minority-owned small business. The contract is for the development of novel, low-cost, real-time point-of-care (POC) assays for HIV viral load monitoring, HIV drug resistance monitoring, and pharmacological adherence monitoring. This contract was awarded under the Small Business Innovation Research (SBIR) Phase I program, which aims to stimulate technological innovation and support small businesses in meeting federal research and development needs. The contract has a completion date of June 30, 2024.
Quick answers
Who was awarded contract 75N93021C00030?
75N93021C00030 was awarded to Zymeron Corporation by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 1, 2021.
How much is contract 75N93021C00030 worth?
The government has obligated $299,988 on 75N93021C00030.
Was contract 75N93021C00030 competed?
The extent of competition for 75N93021C00030 was full and open competition after exclusion of sources. The government received 6 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award